1. Wagner U, Burkhardt E, Failing K. Evaluation of canine lymphocyte proliferation: comparison of three different colorimetric methods with the 3H-thymidine incorporation assay. Vet Immunol Immunopathol. 1999;70(3-4):151-9.
2. Azarsiz E, Karaca N, Ergun B, Durmuscan M, Kutukculer N, Aksu G. In vitro T lymphocyte proliferation by carboxyfluorescein diacetate succinimidyl ester method is helpful in diagnosing and managing primary immunodeficiencies. J Clin Lab Anal. 2018;32(1):e22216.
3. Trickett A, Kwan YL. T cell stimulation and expansion using anti-CD3/CD28 beads. J Immunol Methods. 2003;275(1-2):251-5.
4. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973-80.
5. Lentner C, editor. Geigy Scientific Tables, Switzerland: Ciba-Geigy Ltd, 1984: 8th Edition, Vol 3, 154.
6. Nisbet-Brown ER, Lee JW, Cheung RK, Gelfand EW. Antigen-specific and –nonspecific mitogenic signals in the activation of human T cell clones. J Immunol. 1987;138(11):3713-9.
7. Grimbacher B, Warnatz K, Yong PFK, Korganow AS, Peter HH. The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects. J Allergy Clin Immunol. 2016;137(1):3-17.
8. Jiang J, Tang W, An Y, Tang M, Wu J, Qin T, Zhao X. Molecular and immunological characterization of DNA ligase IV deficiency. Clin Immunol. 2016;163(12):75-83.
9. Roifman CM, Somech R, Kavadas F, Pires L, Nahum A, Dalal I, et al. Defining combined immunodeficiency. J Allergy Clin Immunol. 2012;130(1):177-83.
10. Lašťovička J, Rataj M, Bartůňková J. Assessment of lymphocyte proliferation for diagnostic purpose: Comparison of CFSE staining, Ki-67 expression and 3H-thymidine incorporation. Hum Immunol. 2016;77(12):1215-22.
11. Green L. Development of an anti-CD2/CD3/CD28 bead-based T-cell proliferation assay, Biosci Horiz: Int J Stud Res. 2014; 7.https://doi.org/10.1093/biohorizons/hzu012.
12. Mirzakhani M, Shahbazi M, Darvish S, Mohammadnia-Afrouzi M. Extensive proliferation of CD4+ lymphocyte by both phytohaemagglutinin A and anti-CD2/CD3/ CD28 Macsibeads. Acta Med Bulg. 2018;45(1):22-5.
13. Evavold BD, Allen PM. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 1991;252(5010):1308-10.
14. Keck S, Schmaler M, Ganter S, Wyss L, Oberle S, Huseby ES, Zehn D, King CG. Antigen affinity and antigen dose exert distinct influences on CD4 T-cell differentiation. Proc Natl Acad Sci USA. 2014;111(41):14852-7.
15. Candia M, Kratzer B, Pickl WF. On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy). Int Arch Allergy Immunol. 2016;170(4):211-33.
16. Jensen BS, Odum N, Jorgensen NK, Christophersen P, Olesen SP. Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels. Proc Natl Acad Sci U S A. 1999;96(19):10917-21.